Joel Constans Selected Research

Joel Constans Research Topics

2	Neoplasms (Cancer) 01/2023 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 12/2021
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Pulmonary Embolism 01/2022
1	Thromboembolism 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Hemorrhage 01/2022
1	Giant Cell Arteritis (Horton Disease) 01/2021
1	Chronic Limb-Threatening Ischemia 01/2021
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2018
1	Peripheral Arterial Disease 10/2013
1	Chronic Renal Insufficiency 10/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2003

2	AntibodiesIBA 01/2023 - 09/2003
2	tocilizumab (atlizumab)FDA Link 01/2021 - 01/2018
1	RNA Polymerase IIIIBA 01/2023
1	Anti-Idiotypic AntibodiesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2022
1	RivaroxabanIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	pirfenidoneIBA 12/2021
1	Cortisone FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AutoantibodiesIBA 09/2003
1	anti-endothelial cell antibodyIBA 09/2003

2	Surgical Amputation (Amputations) 01/2021 - 10/2013